Testing physical models of passive membrane permeation

Journal of Chemical Information and Modeling

Volumn 52, Issue 6, 2012, Pages 1621-1636

  Leung, Siegfried S F ^a   Mijalkovic, Jona ^a   Borrelli, Kenneth ^b   Jacobson, Matthew P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCHRÖDINGER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREE ENERGY; MEMBRANES; MOLECULAR MECHANICS;

ARTIFICIAL MEMBRANES; IMPLICIT SOLVENT MODEL; IN-VIVO MEASUREMENT; MEMBRANE PERMEABILITY; MEMBRANE PERMEATION; PERMEABILITY MEASUREMENTS; PERMEABILITY MODEL; STATISTICAL RELATIONSHIP;

PERMEATION;

ANIMAL; ARTICLE; CELL LINE; DIFFUSION; DRUG DESIGN; HUMAN; PERMEABILITY; PHARMACOKINETICS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; THEORETICAL MODEL; THERMODYNAMICS;

ANIMALS; CELL LINE; DIFFUSION; DRUG DESIGN; HUMANS; MODELS, THEORETICAL; PERMEABILITY; PHARMACOKINETICS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; THERMODYNAMICS;

EID: 84862876883     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci200583t     Document Type: Article

References (93)

1. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 1997, 23 (1-3) 3-25
2. Egan, W. J.; Merz, K. M.; Baldwin, J. J. Prediction of drug absorption using multivariate statistics J. Med. Chem. 2000, 43 (21) 3867-3877
3. Ekins, S.; Durst, G. L.; Stratford, R. E.; Thorner, D. A.; Lewis, R.; Loncharich, R. J.; Wikel, J. H. Three-dimensional quantitative structure-permeability relationship analysis for a series of inhibitors of rhinovirus replication J. Chem. Inf. Comput. Sci. 2001, 41 (6) 1578-1586
4. Ekins, S.; Waller, C. L.; Swaan, P. W.; Cruciani, G.; Wrighton, S. A.; Wikel, J. H. Progress in predicting human ADME parameters in silico J. Pharm. Toxicol. Methods 2000, 44 (1) 251-272
5. Ekins, S.; Rose, J. In silico ADME/Tox: The state of the art J. Molec. Graph. Modell. 2001, 20 (4) 305-309
6. Fujikawa, M.; Ano, R.; Nakao, K.; Shimizu, R.; Akamatsu, M. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: Application to prediction of Caco-2 cell permeability Bioorg. Med. Chem. 2005, 13 (15) 4721-4732
7. Fujiwara, S.; Yamashita, F.; Hashida, M. Prediction of Caco-2 cell permeability using a combination of MO-calculation and neural network Int. J. Pharm. 2002, 237 (1-2) 95-105
8. Krarup, L. H.; Christensen, I. T.; Hovgaard, L.; Frokjaer, S. Predicting drug absorption from molecular surface properties based on molecular dynamics simulations Pharm. Res. 1998, 15 (7) 972-978
9. Liu, R. F.; Sun, H. M.; So, S. S. Development of quantitative structure-property relationship models for early ADME evaluation in drug discovery. 2. Blood-brain barrier penetration J. Chem. Inf. Comput. Sci. 2001, 41 (6) 1623-1632
10. Malkia, A.; Murtomaki, L.; Urtti, A.; Kontturi, K. Drug permeation in biomembranes in vitro and in silico prediction and influence of physicochemical properties Eur. J. Pharm. Sci. 2004, 23 (1) 13-47
11. Refsgaard, H. H. F.; Jensen, B. F.; Brockhoff, P. B.; Padkjaer, S. B.; Guldbrandt, M.; Christensen, M. S. In silico prediction of membrane permeability from calculated molecular parameters J. Med. Chem. 2005, 48 (3) 805-811
12. Stouch, T. R.; Kenyon, J. R.; Johnson, S. R.; Chen, X. Q.; Doweyko, A.; Li, Y. In silico ADME/Tox: why models fail J. Comput.-Aided Molec. Design 2003, 17 (2) 83-92
13. Yamashita, F.; Wanchana, S.; Hashida, M. Quantitative structure/property relationship analysis of Caco-2 permeability using a genetic algorithm-based partial least squares method J. Pharm. Sci. 2002, 91 (10) 2230-2239
14. van de Waterbeemd, H.; Gifford, E. ADMET in silico modelling: Towards prediction paradise? Nat. Rev. Drug Discovery 2003, 2 (3) 192-204
15. Dudek, A. Z.; Arodz, T.; Galvez, J. Computational methods in developing quantitative structure-activity relationships (QSAR): A review Comb. Chem. High Throughput Screen. 2006, 9 (3) 213-228
16. Katritzky, A. R.; Kuanar, M.; Slavov, S.; Hall, C. D.; Karelson, M.; Kahn, I.; Dobchev, D. A. Quantitative Correlation of Physical and Chemical Properties with Chemical Structure: Utility for Prediction Chem. Rev. 2010, 110 (10) 5714-5789
17. Yoshida, F.; Topliss, J. G. QSAR model for drug human oral bioavailability (vol 43, pg 2578, 2000) J. Med. Chem. 2000, 43 (24) 4723-4723
18. Suenderhauf, C.; Hammann, F.; Maunz, A.; Helma, C.; Huwyler, J. Combinatorial QSAR Modeling of Human Intestinal Absorption Mol. Pharmaceutics 2011, 8 (1) 213-224
19. Potts, R. O.; Guy, R. H. A Predictive Algorithm for Skin Permeability - The Effects of Molecular-Size and Hydrogen-Bond Activity Pharm. Res. 1995, 12 (11) 1628-1633
20. Ottaviani, G.; Martel, S.; Carrupt, P. A. In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities J. Med. Chem. 2007, 50 (4) 742-748
21. Zhao, Y. H.; Abraham, M. H.; Ibrahim, A.; Fish, P. V.; Cole, S.; Lewis, M. L.; de Groot, M. J.; Reynolds, D. P. Predicting penetration across the blood-brain barrier from simple descriptors and fragmentation schemes J. Chem. Inf. Model. 2007, 47 (1) 170-175
22. Zhang, L.; Zhu, H.; Oprea, T. I.; Golbraikh, A.; Tropsha, A. QSAR modeling of the Blood-Brain Barrier permeability for diverse organic compounds Pharm. Res. 2008, 25 (8) 1902-1914
23. Aller, S. G.; Yu, J.; Ward, A.; Weng, Y.; Chittaboina, S.; Zhuo, R. P.; Harrell, P. M.; Trinh, Y. T.; Zhang, Q. H.; Urbatsch, I. L.; Chang, G. Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding Science 2009, 323 (5922) 1718-1722
24. Dolghih, E.; Bryant, C.; Renslo, A. R.; Jacobson, M. P. Predicting Binding to P-Glycoprotein by Flexible Receptor Docking PloS Comput. Biol. 2011, 7 (6) 11
25. Adson, A.; Raub, T. J.; Burton, P. S.; Barsuhn, C. L.; Hilgers, A. R.; Audus, K. L.; Ho, N. F. H. Quantitative approaches to delineate paracellular diffusion in cultured epithelial-cell monolayers J. Pharm. Sci. 1994, 83 (11) 1529-1536
26. Knipp, G. T.; Ho, N. F. H.; Barsuhn, C. L.; Borchardt, R. T. Paracellular diffusion in Caco-2 cell monolayers: Effect of perturbation on the transport of hydrophilic compounds that vary in charge and size J. Pharm. Sci. 1997, 86 (10) 1105-1110
27. Matsson, P.; Bergstrom, C. A. S.; Nagahara, N.; Tavelin, S.; Norinder, U.; Artursson, P. Exploring the role of different drug transport routes in permeability screening J. Med. Chem. 2005, 48 (2) 604-613
28. Alper, H. E.; Stouch, T. R. Orientation and diffusion of a drug analog in biomembranes: molecular dynamic simulations J. Phys. Chem. 1995, 99 (15) 5724-5731
29. Bemporad, D.; Essex, J. W.; Luttmann, C. Permeation of small molecules through a lipid bilayer: A computer simulation study J. Phys. Chem. B 2004, 108 (15) 4875-4884
30. Bemporad, D.; Luttmann, C.; Essex, J. W. Computer simulation of small molecule permeation across a lipid bilayer: Dependence on bilayer properties and solute volume, size, and cross-sectional area Biophys. J. 2004, 87 (1) 1-13
31. Bemporad, D.; Luttmann, C.; Essex, J. W. Behaviour of small solutes and large drugs in a lipid bilayer from computer simulations Biochim. Biophys. Acta-Biomembr. 2005, 1718 (1-2) 1-21
32. Marrink, S. J.; Berendsen, H. J. C. Permeation process of small molecules across lipid membranes studied by molecular dynamics simulations J. Phys. Chem. 1996, 100 (41) 16729-16738
33. Wilson, M. A.; Pohorille, A. Mechanism of unassisted ion transport across membrane bilayers J. Am. Chem. Soc. 1996, 118 (28) 6580-6587
34. Xiang, T. X.; Anderson, B. D. A computer simulation of functional group contributions to free energy in water and a DPPC lipid bilayer Biophys. J. 2002, 82 (4) 2052-2066
35. Eriksson, E. S. E.; dos Santos, D.; Guedes, R. C.; Eriksson, L. A. Properties and Permeability of Hypericin and Brominated Hypericin in Lipid Membranes J. Chem. Theory Comput. 2009, 5 (12) 3139-3149
36. Eriksson, E. S. E.; Eriksson, L. A. The Influence of Cholesterol on the Properties and Permeability of Hypericin Derivatives in Lipid Membranes J. Chem. Theory Comput. 2011, 7 (3) 560-574
37. Iyer, M.; Mishra, R.; Han, Y.; Hopfinger, A. J. Predicting blood-brain barrier partitioning of organic molecules using membrane-interaction QSAR analysis Pharm. Res. 2002, 19 (11) 1611-1621
38. Iyer, M.; Tseng, Y. J.; Senese, C. L.; Liu, J. Z.; Hopfinger, A. J. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis Mol. Pharmaceutics 2007, 4 (2) 218-231
39. Kulkarni, A.; Han, Y.; Hopfinger, A. J. Predicting caco-2 cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis J. Chem. Inf. Comput. Sci. 2002, 42 (2) 331-342
40. Liu, J. Z.; Li, Y.; Pan, D. H.; Hopfinger, A. J. Predicting permeability coefficient in ADMET evaluation by using different membranes-interaction QSAR Int. J. Pharm. 2005, 304 (1-2) 115-123
41. Santos, O. A.; Hopfinger, A. J. Combined 4D-Fingerprint and clustering based membrane-interaction QSAR analyses for constructing consensus Caco-2 cell permeation virtual screens J. Pharm. Sci. 2008, 97 (1) 566-583
42. Bennett, W. F. D.; Tieleman, D. P. Water Defect and Pore Formation in Atomistic and Coarse-Grained Lipid Membranes: Pushing the Limits of Coarse Graining J. Chem. Theory Comput. 2011, 7 (9) 2981-2988
43. De Nicola, A.; Zhao, Y.; Kawakatsu, T.; Roccatano, D.; Milano, G. Hybrid Particle-Field Coarse-Grained Models for Biological Phospholipids J. Chem. Theory Comput. 2011, 7 (9) 2947-2962
44. Orsi, M.; Michel, J.; Essex, J. W. Coarse-grain modelling of DMPC and DOPC lipid bilayers J. Phys.: Condens. Matter 2010, 22 (15) 15
45. Orsi, M.; Essex, J. W. Permeability of drugs and hormones through a lipid bilayer: insights from dual-resolution molecular dynamics Soft Matter 2010, 6 (16) 3797-3808
46. Spassov, V. Z.; Yan, L.; Szalma, S. Introducing an implicit membrane in generalized Born/solvent accessibility continuum solvent models J. Phys. Chem. B 2002, 106 (34) 8726-8738
47. Tanizaki, S.; Feig, M. A generalized Born formalism for heterogeneous dielectric environments: Application to the implicit modeling of biological membranes J. Chem. Phys. 2005, 122, 12
48. Ulmschneider, M. B.; Ulmschneider, J. P.; Sansom, M. S. P.; Di Nola, A. A generalized Born implicit-membrane representation compared to experimental insertion free energies Biophys. J. 2007, 92, 2338-2349
49. Parisio, G.; Ferrarini, A. Solute Partitioning into Lipid Bilayers: An Implicit Model for Nonuniform and Ordered Environment J. Chem. Theory Comput. 2010, 2267-2280
50. Diamond, J. M.; Katz, Y. Interpretation of nonelectrolyte partition-coefficients between dimyristoyl lecithin and water J. Membr. Biol. 1974, 17 (2) 121-154
51. Walter, A.; Gutknecht, J. Permeability of small nonelectrolytes through lipid bilayer-membranes J. Membr. Biol. 1986, 90 (3) 207-217
52. Xiang, T. X. A computer-simulation of free-volume distributions and related structural-properties in a model lipid bilayer Biophys. J. 1993, 65 (3) 1108-1120
53. Xiang, T. X.; Anderson, B. D. Molecular distributions in interphases: statistical mechanical theory combined with molecular dynamics simulation of a model lipid bilayer Biophys. J. 1994, 66 (3) 561-572
54. Xiang, T. X.; Anderson, B. D. The relationship between permeant size and permeability in lipid bilayer-membranes J. Membr. Biol. 1994, 140 (2) 111-122
55. Xiang, T. X.; Anderson, B. D. Phospholipid surface-density determines the partitioning and permeability of acetic-acid in DMPC:cholesterol bilayers J. Membr. Biol. 1995, 148 (2) 157-167
56. Xiang, T. X.; Anderson, B. D. Permeability of acetic acid across gel and liquid-crystalline lipid bilayers conforms to free-surface-area theory Biophys. J. 1997, 72 (1) 223-237
57. Xiang, T. X.; Anderson, B. D. Influence of chain ordering on the selectivity of dipalmitoylphosphatidylcholine bilayer membranes for permeant size and shape Biophys. J. 1998, 75 (6) 2658-2671
58. Xiang, T. X.; Chen, J.; Anderson, B. D. A quantitative model for the dependence of solute permeability on peptide and cholesterol content in biomembranes J. Membr. Biol. 2000, 177 (2) 137-148
59. Gerebtzoff, G.; Seelig, A. In silico prediction of blood-Brain barrier permeation using the calculated molecular cross-sectional area as main parameter J. Chem. Inf. Model. 2006, 46, 2638-2650
60. Seelig, A. The role of size and charge for blood-brain barrier permeation of drugs and fatty acids J. Molec. Neurosci. 2007, 33 (1) 32-41
61. Rezai, T.; Yu, B.; Millhauser, G. L.; Jacobson, M. P.; Lokey, R. S. Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers J. Am. Chem. Soc. 2006, 128 (8) 2510-2511
62. Rezai, T.; Bock, J. E.; Zhou, M. V.; Kalyanaraman, C.; Lokey, R. S.; Jacobson, M. P. Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: Successful in silico prediction of the relative permeabilities of cyclic peptides J. Am. Chem. Soc. 2006, 128 (43) 14073-14080
63. Kalyanaraman, C.; Jacobson, M. P. An atomistic model of passive membrane permeability: application to a series of FDA approved drugs J. Comput.-Aided Molec. Des. 2007, 21 (12) 675-679
64. White, T. R.; Renzelman, C. M.; Rand, A. C.; Rezai, T.; McEwen, C. M.; Gelev, V. M.; Turner, R. A.; Linington, R. G.; Leung, S. S. F.; Kalgutkar, A. S.; Bauman, J. N.; Zhang, Y.; Liras, S.; Price, D. A.; Mathiowetz, A. M.; Jacobson, M. P.; Lokey, R. S. On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds Nat. Chem. Biol. 2011, 7 (11) 810-817
65. Rafi, S. B.; Hearn, B. R.; Vedantham, P.; Jacobson, M. P.; Renslo, A. R. Predicting and improving the membrane permeability of peptide small molecules J. Med. Chem. 2012, 55 (7) 3163-3169
66. Avdeef, A.; Artursson, P.; Neuhoff, S.; Lazorova, L.; Grasjo, J.; Tavelin, S. Caco-2 permeability of weakly basic drugs predicted with the Double-Sink PAMPA pK(a)(flux) method Eur. J. Pharm. Sci. 2005, 24 (4) 333-349
67. Balimane, P. V.; Han, Y. H.; Chong, S. H. Current industrial practices of assessing permeability and P-glycoprotein interaction Aaps J. 2006, 8 (1) E1-E13
68. Bermejo, M.; Avdeef, A.; Ruiz, A.; Nalda, R.; Ruell, J. A.; Tsinman, O.; Gonzalez, I.; Fernandez, C.; Sanchez, G.; Garrigues, T. M.; Merino, V. PAMPA-a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones Eur. J. Pharm. Sci. 2004, 21 (4) 429-441
69. Di, L.; Kerns, E. H.; Fan, K.; McConnell, O. J.; Carter, G. T. High throughput artificial membrane permeability assay for blood-brain barrier Eur. J. Med. Chem. 2003, 38 (3) 223-232
70. Fujikawa, M.; Nakao, K.; Shimizu, R.; Akamatsu, M. QSAR study on permeability of hydrophobic compounds with artificial membranes Bioorg. Med. Chem. 2007, 15 (11) 3756-3767
71. Goodwin, J. T.; Conradi, R. A.; Ho, N. F. H.; Burton, P. S. Physicochemical determinants of passive membrane permeability: Role of solute hydrogen-bonding potential and volume J. Med. Chem. 2001, 44, 3721-3729
72. Irvine, J. D.; Takahashi, L.; Lockhart, K.; Cheong, J.; Tolan, J. W.; Selick, H. E.; Grove, J. R. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening J. Pharm. Sci. 1999, 88 (1) 28-33
73. Li, C.; Nair, L.; Liu, T. T.; Li, F. B.; Pichardo, J.; Agrawal, S.; Chase, R.; Tong, X.; Uss, A. S.; Bogen, S.; Njoroge, F. G.; Morrison, R. A.; Cheng, K. C. Correlation between PAMPA permeability and cellular activities of hepatitis C virus protease inhibitors Biochem. Pharmacol. 2008, 75 (5) 1186-1197
74. Whitlock, G. A.; Blagg, J.; Fish, P. V. 1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity Bioorg. Med. Chem. Lett. 2008, 18 (2) 596-599
75. Di, L.; Whitney-Pickett, C.; Umland, J. P.; Zhang, H.; Zhang, X.; Gebhard, D. F.; Lai, Y. R.; Federico, J. J.; Davidson, R. E.; Smith, R.; Reyner, E. L.; Lee, C.; Feng, B.; Rotte, C.; Varma, M. V.; Kempshall, S.; Fenner, K.; El-Kattan, A. F.; Liston, T. E.; Troutman, M. D. Development of a New Permeability Assay Using Low-Efflux MDCKII Cells J. Pharm. Sci. 2011, 100 (11) 4974-4985
76. Martín-Villodre, A.; Plá-Delfina, J. M.; Moreno, J.; Pérez-Buendía, D.; Miralles, J.; Collado, E. F.; Sánchez-Moyano, E.; Del Pozo, A. Studies on the reliability of a bihyperbolic functional absorption-model. I. Ring-substituted anilines J. Pharm. Biopharm. 1986, 14 (6) 615-633
77. Marqusee, J. A.; Dill, K. A. Solute partitioning into chain molecule interphases - monolayers, bilayer-membranes, and micelles J. Chem. Phys. 1986, 85 (1) 434-444
78. Shore, P. A.; Brodie, B. B.; Hogben, C. A. M. The gastric secretion of drugs: a pH partition hypothesis J. Pharm. Exp. Therap. 1957, 119 (3) 361-369
79. Tirado-Rives, J.; Jorgensen, W. L. Contribution of conformer focusing to the uncertainty in predicting free energies for protein-ligand binding J. Med. Chem. 2006, 49 (20) 5880-5884
80. Guimarães, C. R. W.; Cardozo, M. MM-GB/SA rescoring of docking poses in structure-based lead optimization J. Chem. Inf. Model. 2008, 48 (5) 958-970
81. Maestro, version 9.0, Schrödinger, LLC, New York, NY, 2009.
82. MacroModel, version 9.7, Schrödinger, LLC, New York, NY, 2009.
83. Jorgensen, W. L.; Maxwell, D. S.; TiradoRives, J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids J. Am. Chem. Soc. 1996, 118 (45) 11225-11236
84. Kaminski, G. A.; Friesner, R. A.; Tirado-Rives, J.; Jorgensen, W. L. Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides J. Phys. Chem. B 2001, 105 (28) 6474-6487
85. QikProp, version 3.2, Schrödinger, LLC, New York, NY, 2009.
86. Epik, version 2.0, Schrödinger, LLC, New York, NY, 2009.
87. Shelley, J. C.; Cholleti, A.; Frye, L. L.; Greenwood, J. R.; Timlin, M. R.; Uchimaya, M. Epik: a software program for pK (a) prediction and protonation state generation for drug-like molecules J. Comput.-Aided Molec. Design 2007, 21 (12) 681-691
88. Jacobson, M. P.; Pincus, D. L.; Rapp, C. S.; Day, T. J. F.; Honig, B.; Shaw, D. E.; Friesner, R. A. A hierarchical approach to all-atom protein loop prediction Proteins-Struct. Funct. Bioinf. 2004, 55 (2) 351-367
89. Gallicchio, E.; Zhang, L. Y.; Levy, R. M. The SGB/NP hydration free energy model based on the surface generalized born solvent reaction field and novel nonpolar hydration free energy estimators J. Comput. Chem. 2002, 23 (5) 517-529
90. Ghosh, A.; Rapp, C. S.; Friesner, R. A. Generalized born model based on a surface integral formulation J. Phys. Chem. B 1998, 102 (52) 10983-10990
91. Luo, R.; Head, M. S.; Given, J. A.; Gilson, M. K. Nucleic acid base-pairing and N-methylacetamide self-association in chloroform: affinity and conformation Biophys. Chem. 1999, 78 (1-2) 183-193
92. Prime, version 3.1, Schrödinger, LLC, New York, NY, 2012.
93. Swift, R. V.; Amaro, R. E. Modeling the pharmacodynamics of passive membrane permeability J. Comput.-Aided Molec. Design 2011, 25 (11) 1007-1017